Cargando…

Docking study of transmembrane serine protease type 2 inhibitors for the treatment of COVID-19

The recent pandemic development of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its quick national and international spread present a global health emergency. Entry of coronaviruses into the cell depends on binding of the viral spike (S) proteins to host cells receptors...

Descripción completa

Detalles Bibliográficos
Autor principal:	Solanki, Naishadh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988994/ http://dx.doi.org/10.1016/B978-0-323-90769-9.00029-3

Ejemplares similares

Interaction of Protein C Inhibitor with the Type II Transmembrane Serine Protease Enteropeptidase
por: Prohaska, Thomas A., et al.
Publicado: (2012)

Association of the Transmembrane Serine Protease-2 (TMPRSS2) Polymorphisms with COVID-19
por: Posadas-Sánchez, Rosalinda, et al.
Publicado: (2022)

Identification of novel transmembrane Protease Serine Type 2 drug candidates for COVID-19 using computational studies
por: Elbadwi, Fatima A., et al.
Publicado: (2021)

Potential Simultaneous Inhibitors of Angiotensin-Converting Enzyme 2 and Transmembrane Protease, Serine 2
por: Wu, Ching-Yuan, et al.
Publicado: (2020)

Magnesium treatment on methylation changes of transmembrane serine protease 2 (TMPRSS2)
por: Fan, Lei, et al.
Publicado: (2021)

Molecular Insights into Human Transmembrane Protease Serine-2 (TMPS2) Inhibitors against SARS-CoV2: Homology Modelling, Molecular Dynamics, and Docking Studies
por: Kishk, Safaa M., et al.
Publicado: (2020)

Evolutionary history of type II transmembrane serine proteases involved in viral priming
por: Forni, Diego, et al.
Publicado: (2022)

Type II Transmembrane Serine Protease Gene Variants Associate with Breast Cancer
por: Luostari, Kaisa, et al.
Publicado: (2014)

Type II Transmembrane Serine Proteases as Modulators in Adipose Tissue Phenotype and Function
por: Wu, Qingyu, et al.
Publicado: (2023)

Transmembrane serine protease 2 is a prognostic factor for lung adenocarcinoma
por: Schneider, Marc A., et al.
Publicado: (2022)

RAndomized Clinical Trial Of NAfamostat Mesylate, A Potent Transmembrane Protease Serine 2 (TMPRSS2) Inhibitor, in Patients with COVID-19 Pneumonia
por: Seccia, Teresa Maria, et al.
Publicado: (2023)

Serine protease inhibitors could be of benefit in the treatment of COVID-19 disease
por: Okeahialam, Basil N.
Publicado: (2021)

Transmembrane serine protease 2 and angiotensin-converting enzyme 2 anti-inflammatory receptors for COVID-19/inflammatory bowel diseases treatment
por: Lashgari, Naser-Aldin, et al.
Publicado: (2021)

Transmembrane protease serine 2 (TMPRSS2) rs75603675, comorbidity, and sex are the primary predictors of COVID-19 severity
por: Villapalos-García, Gonzalo, et al.
Publicado: (2022)

Simultaneous Treatment of COVID-19 With Serine Protease Inhibitor Camostat and/or Cathepsin L Inhibitor?
por: Bittmann, Stefan, et al.
Publicado: (2020)

Dysregulation of Type II Transmembrane Serine Proteases and Ligand-Dependent Activation of MET in Urological Cancers
por: Mukai, Shoichiro, et al.
Publicado: (2020)

In-silico screening for identification of potential inhibitors against SARS-CoV-2 transmembrane serine protease 2 (TMPRSS2)
por: Barge, Sagar, et al.
Publicado: (2021)

Correction: Transmembrane protease serine 2 (TMPRSS2) rs75603675, comorbidity and sex are the primary predictors of Covid-19 severity
por: Villapalos-García, Gonzalo, et al.
Publicado: (2022)

Intracellular autoactivation of TMPRSS11A, an airway epithelial transmembrane serine protease
por: Zhang, Ce, et al.
Publicado: (2020)

TMPRSS4, a type II transmembrane serine protease, as a potential therapeutic target in cancer
por: Kim, Semi
Publicado: (2023)

Pharmacoinformatics-based identification of transmembrane protease serine-2 inhibitors from Morus Alba as SARS-CoV-2 cell entry inhibitors
por: Shakya, Anshul, et al.
Publicado: (2021)

Unravelling high-affinity binding compounds towards transmembrane protease serine 2 enzyme in treating SARS-CoV-2 infection using molecular modelling and docking studies
por: M, Pooja, et al.
Publicado: (2021)

The role of Serine Proteases and Serine Protease Inhibitors in the migration of Gonadotropin-Releasing Hormone neurons
por: Drapkin, Paola T, et al.
Publicado: (2002)

The human Transmembrane Protease Serine 2 is necessary for the production of Group 2 influenza A virus pseudotypes
por: Ferrara, Francesca, et al.
Publicado: (2013)

rs12329760 Polymorphism in Transmembrane Serine Protease 2 Gene and Risk of Coronavirus Disease 2019 Mortality
por: Beheshti Shirazi, Saeedeh Sadat, et al.
Publicado: (2022)

Impacts of transmembrane serine protease 4 expression on susceptibility to severe acute respiratory syndrome coronavirus 2
por: Tan, Qi, et al.
Publicado: (2023)

Computational screening of phytochemicals from three medicinal plants as inhibitors of transmembrane protease serine 2 implicated in SARS-CoV-2 infection
por: Oyedara, Omotayo O., et al.
Publicado: (2021)

The Transmembrane Protease TMPRSS2 as a Therapeutic Target for COVID-19 Treatment
por: Wettstein, Lukas, et al.
Publicado: (2022)

Cathepsin L, transmembrane peptidase/serine subfamily member 2/4, and other host proteases in COVID-19 pathogenesis – with impact on gastrointestinal tract
por: Berdowska, Izabela, et al.
Publicado: (2021)

Pan-cancer analysis of transmembrane protease serine 2 and cathepsin L that mediate cellular SARS-CoV-2 infection leading to COVID-19
por: Katopodis, Periklis, et al.
Publicado: (2020)

Transmembrane serine protease 2 Polymorphisms and Susceptibility to Severe Acute Respiratory Syndrome Coronavirus Type 2 Infection: A German Case-Control Study
por: Schönfelder, Kristina, et al.
Publicado: (2021)

Unexpected Activity of a Novel Kunitz-type Inhibitor: INHIBITION OF CYSTEINE PROTEASES BUT NOT SERINE PROTEASES
por: Smith, David, et al.
Publicado: (2016)

Hybrid drug-screening strategy identifies potential SARS-CoV-2 cell-entry inhibitors targeting human transmembrane serine protease
por: Feng, Yufei, et al.
Publicado: (2022)

The Proteolytic Activation of (H3N2) Influenza A Virus Hemagglutinin Is Facilitated by Different Type II Transmembrane Serine Proteases
por: Kühn, Nora, et al.
Publicado: (2016)

Computational Analysis of Missense Variants in the Human Transmembrane Protease Serine 2 (TMPRSS2) and SARS-CoV-2
por: Saih, Asmae, et al.
Publicado: (2021)

Editorial: Serine protease inhibitors and their therapeutic applications
por: Crocetti, Letizia, et al.
Publicado: (2022)

Diarylethene‐Based Photoswitchable Inhibitors of Serine Proteases
por: Babii, Oleg, et al.
Publicado: (2021)

TMEFF2 shedding is regulated by oxidative stress and mediated by ADAMs and transmembrane serine proteases implicated in prostate cancer
por: Gaweł‐Bęben, Katarzyna, et al.
Publicado: (2017)

Angiotensin‐converting enzyme 2 and transmembrane protease serine 2 in female and male patients with end‐stage kidney disease
por: Arefin, Samsul, et al.
Publicado: (2022)

Transmembrane Protein Docking with JabberDock
por: Rudden, Lucas S. P., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rn47piapke3ru5t27i3u4bq6ot